669 related articles for article (PubMed ID: 28223228)
1. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
[TBL] [Abstract][Full Text] [Related]
2. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
3. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
4. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
Suh W
Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG
Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255
[TBL] [Abstract][Full Text] [Related]
6. Exploiting urine-derived induced pluripotent stem cells for advancing precision medicine in cell therapy, disease modeling, and drug testing.
Yin X; Li Q; Shu Y; Wang H; Thomas B; Maxwell JT; Zhang Y
J Biomed Sci; 2024 May; 31(1):47. PubMed ID: 38724973
[TBL] [Abstract][Full Text] [Related]
7. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
[TBL] [Abstract][Full Text] [Related]
8. Induced Pluripotent Stem Cells in Drug Discovery and Neurodegenerative Disease Modelling.
Beghini DG; Kasai-Brunswick TH; Henriques-Pons A
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397069
[TBL] [Abstract][Full Text] [Related]
9. Pluripotent stem cells for neurodegenerative disease modeling: an expert view on their value to drug discovery.
Chen SD; Li HQ; Cui M; Dong Q; Yu JT
Expert Opin Drug Discov; 2020 Sep; 15(9):1081-1094. PubMed ID: 32425128
[TBL] [Abstract][Full Text] [Related]
10. Self-Organized Cerebellar Tissue from Human Pluripotent Stem Cells and Disease Modeling with Patient-Derived iPSCs.
Muguruma K
Cerebellum; 2018 Feb; 17(1):37-41. PubMed ID: 29196977
[TBL] [Abstract][Full Text] [Related]
11. Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening.
Chang CY; Ting HC; Liu CA; Su HL; Chiou TW; Lin SZ; Harn HJ; Ho TJ
Molecules; 2020 Apr; 25(8):. PubMed ID: 32344649
[TBL] [Abstract][Full Text] [Related]
12. iPSC technology: platform for drug discovery. Point.
Ellis J; Bhatia M
Clin Pharmacol Ther; 2011 May; 89(5):639-41. PubMed ID: 21512521
[TBL] [Abstract][Full Text] [Related]
13. Induced Pluripotent Stem Cells for Disease Modeling and Drug Discovery in Neurodegenerative Diseases.
Cao L; Tan L; Jiang T; Zhu XC; Yu JT
Mol Neurobiol; 2015 Aug; 52(1):244-55. PubMed ID: 25146848
[TBL] [Abstract][Full Text] [Related]
14. Advancing drug discovery for neuropsychiatric disorders using patient-specific stem cell models.
Haggarty SJ; Silva MC; Cross A; Brandon NJ; Perlis RH
Mol Cell Neurosci; 2016 Jun; 73():104-15. PubMed ID: 26826498
[TBL] [Abstract][Full Text] [Related]
15. Advances in reprogramming-based study of neurologic disorders.
Nityanandam A; Baldwin KK
Stem Cells Dev; 2015 Jun; 24(11):1265-83. PubMed ID: 25749371
[TBL] [Abstract][Full Text] [Related]
16. Research on neurodegenerative diseases using induced pluripotent stem cells.
Imamura K; Inoue H
Psychogeriatrics; 2012 Jun; 12(2):115-9. PubMed ID: 22712645
[TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
Gao A; Peng Y; Deng Y; Qing H
Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
[TBL] [Abstract][Full Text] [Related]
18. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders.
Okano H; Morimoto S
Cell Stem Cell; 2022 Feb; 29(2):189-208. PubMed ID: 35120619
[TBL] [Abstract][Full Text] [Related]
19. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
Qian L; Tcw J
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
[TBL] [Abstract][Full Text] [Related]
20. Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine.
Sayed N; Liu C; Wu JC
J Am Coll Cardiol; 2016 May; 67(18):2161-2176. PubMed ID: 27151349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
